IVST | N | Normal-mild (n=173) | Moderate-severe (n=252) | p Value |
---|---|---|---|---|
Clinical | ||||
Age ≥55 years, n (%) | 425 | 56 (32) | 214 (85) | <0.0001 |
NYHA II–IV, n (%) | 190 | 18 (75) | 152 (92) | 0.0134 |
Male, n (%) | 425 | 107 (62) | 205 (81) | <0.0001 |
SBP ≥140 mm Hg, n (%) | 374 | 19 (12) | 30 (14) | 0.7141 |
Sensory neuropathy, n (%) | 425 | 148 (86) | 146 (58) | <0.0001 |
Motor neuropathy, n (%) | 425 | 64 (37) | 102 (41) | 0.4698 |
ECG | ||||
Low voltage, n (%) | 265 | 7 (7) | 54 (33) | <0.0001 |
Q waves, n (%) | 229 | 5 (10) | 68 (38) | 0.0002 |
Echo | ||||
LVEF <50%, n (%) | 327 | 18 (14) | 98 (49) | <0.0001 |
Posterior wall moderate or severe hypertrophy (women ≥13 mm, men ≥14 mm), n (%) | 403 | 0 (0) | 165 (69) | <0.0001 |
IVST/PWT ratio >1.3, n (%) | 403 | 11 (7) | 49 (21) | 0.0001 |
E/A >2, n (%) | 109 | 5 (7) | 7 (18) | 0.0705 |
E/Ea mean >15, n (%) | 60 | 4 (8) | 4 (40) | 0.0066 |
RV free wall thickness ≥7 mm, n (%) | 87 | 20 (42) | 30 (77) | 0.0009 |
LAD >40 mm, n (%) | 359 | 26 (18) | 171 (79) | <0.0001 |
Sparkling, n (%) | 299 | 40 (36) | 123 (66) | <0.0001 |
Aortic thickening, n (%) | 225 | 15 (19) | 54 (37) | 0.0052 |
Mitral thickening, n (%) | 228 | 9 (11) | 65 (44) | <0.0001 |
Tricuspid thickening, n (%) | 221 | 2 (3) | 20 (14) | 0.0053 |
IVST, interventricular septal thickness; LAD, left atrial diameter; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; PWT, posterior wall thickness; RV, right ventricle; SBP, systolic blood pressure.